Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 21 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06902376
- Conditions
- Anaplastic Thyroid Cancer, BRAF Mutation-Related Tumors, Carcinoma, +11 more
- Locations
-
- Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
NCT06374602
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Saint Petersburg State University Hospital Saint Petersburg, Russia
Recruiting
Sacituzumab govitEcan in THYroid Cancers
NCT06235216
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Differentiated Thyroid Cancer, +4 more
- Locations
-
- Hospital Universitari Vall d'Hebron Barcelona, Spain
- Complexo Hospitalario Universitario de Ferrol Ferrol, Spain
- Institut Catala d´Oncologia (ICO) -Hospitalet Hospitalet de Llobregat (Barcelona), Spain
- Hospital Clínico San Carlos Madrid, Spain
NCT06079333
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Ellen Kapiteijn Leiden, South Holland, Netherlands
Not Yet Recruiting
Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial
NCT07485569
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Differentiated Thyroid Cancer, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
NCT07470489
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT04400474
- Conditions
- Adenocarcinoma, Anaplastic Thyroid Cancer, Carcinoma, +11 more
- Locations
-
- Hospital Germans Trias i Pujol - ICO Badalona Badalona, Barcelona, Spain
- Hospital Duran i Reynals - ICO L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
- Hospital General Universitario Elche Alicante, Spain
- Hospital Universitari Vall d'Hebron Barcelona, Spain
NCT04552769
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Endocrine Gland Neoplasms, +11 more
- Locations
-
- Stanford University Stanford, California, United States
NCT02152137
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Endocrine Gland Neoplasms, +10 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
NCT02244463
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Differentiated Thyroid Cancer, +11 more
- Locations
-
- Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Michigan Medical School Ann Arbor, Michigan, United States
NCT02404441
- Conditions
- Anaplastic Thyroid Cancer, Breast Diseases, Breast Neoplasms, +27 more
- Locations
-
- The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Johns Hopkins Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Oregon Health and Science University SC-10 Portland, Oregon, United States
- Sarah Cannon Research Institute SCRI RC Nashville, Tennessee, United States
NCT02688608
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
Completed
Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer
NCT02726503
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Nagoya University Hospital Nagoya, Aichi-ken, Japan
- Fujita Health University Hospital Toyoake, Aichi-ken, Japan
- IUHW Ichikawa Hospital Ichikawa, Chiba, Japan
- National Cancer Center Hospital East Kashiwa, Chiba, Japan
NCT01240590
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +4 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00068497
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +132 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
NCT00280852
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Tom Baker Cancer Centre Calgary, Alberta, Canada
Active, Not Recruiting
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
NCT03085056
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
Active, Not Recruiting
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
NCT04238624
- Conditions
- Anaplastic Thyroid Cancer, BRAF Gene Mutation, BRAF Mutation-Related Tumors, +12 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
Active, Not Recruiting
Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)
NCT05696548
- Conditions
- Anaplastic Thyroid Cancer, Carcinoma, Neoplasms, +3 more
- Locations
-
- Aichi Cancer Center Nagoya, Aichi-ken, Japan
- National Cancer Center Hospital East Kashiwa, Chiba, Japan
- Hokkaido University Hospital Hokkaido, Japan
- Hyogo Cancer Center Akashi, Hyōgo, Japan